StockData
ResMed Inc logo

ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3014% below fair value
$242.61+4.76 (+2.00%)

Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%

ResMed operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

ResMed's operating income for the twelve months ending Sep 30, 2026 was $1.89B, up 8.5% year over year. For fiscal 2026 it was $1.89B, up 11.9% from the year before. Over ten years it grew 16.0% a year on average. The highest annual figure on record is $1.89B in fiscal 2026.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026$1.89B+11.9%
FY2025Jun 30, 2025$1.69B+27.7%
FY2024Jun 30, 2024$1.32B+16.6%
FY2023Jun 30, 2023$1.13B+13.2%
FY2022Jun 30, 2022$1.00B+10.7%
FY2021Jun 30, 2021$903.68M+11.6%
FY2020Jun 30, 2020$809.66M+39.8%
FY2019Jun 30, 2019$579.26M+6.9%
FY2018Jun 30, 2018$541.83M+27.3%
FY2017Jun 30, 2017$425.80M-0.7%
FY2016Jun 30, 2016$428.95M+4.8%
FY2015Jun 30, 2015$409.24M+1.0%
FY2014Jun 30, 2014$405.09M+14.2%
FY2013Jun 30, 2013$354.82M+20.5%
FY2012Jun 30, 2012$294.41M+10.3%
FY2011Jun 30, 2011$266.92M+11.0%
FY2010Jun 30, 2010$240.38M+26.3%
FY2009Jun 30, 2009$190.31M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$452.98M+1.4%
Q4 FY2026CQ2 2026Jun 30, 2026$448.71M-1.3%
Q3 FY2026CQ1 2026Mar 31, 2026$499.81M+17.3%
Q2 FY2026CQ4 2025Dec 31, 2025$491.66M+17.8%
Q1 FY2026CQ3 2025Sep 30, 2025$446.54M+15.3%
Q4 FY2025CQ2 2025Jun 30, 2025$454.54M+19.2%
Q3 FY2025CQ1 2025Mar 31, 2025$426.27M+13.8%
Q2 FY2025CQ4 2024Dec 31, 2024$417.24M+51.7%
Q1 FY2025CQ3 2024Sep 30, 2024$387.31M+34.0%
Q4 FY2024CQ2 2024Jun 30, 2024$381.22M+38.5%
Q3 FY2024CQ1 2024Mar 31, 2024$374.58M+24.6%
Q2 FY2024CQ4 2023Dec 31, 2023$275.09M-1.8%
Q1 FY2024CQ3 2023Sep 30, 2023$289.00M+4.8%
Q4 FY2023CQ2 2023Jun 30, 2023$275.27M+7.8%
Q3 FY2023CQ1 2023Mar 31, 2023$300.67M+28.3%
Q2 FY2023CQ4 2022Dec 31, 2022$280.19M+12.7%
Q1 FY2023CQ3 2022Sep 30, 2022$275.74M+5.3%
Q4 FY2022CQ2 2022Jun 30, 2022$255.40M+5.7%
Q3 FY2022CQ1 2022Mar 31, 2022$234.27M+4.9%
Q2 FY2022CQ4 2021Dec 31, 2021$248.71M+12.2%
Q1 FY2022CQ3 2021Sep 30, 2021$261.91M+20.8%
Q4 FY2021CQ2 2021Jun 30, 2021$241.64M+8.2%
Q3 FY2021CQ1 2021Mar 31, 2021$223.43M+2.7%
Q2 FY2021CQ4 2020Dec 31, 2020$221.72M+12.1%
Q1 FY2021CQ3 2020Sep 30, 2020$216.90M+26.8%
Q4 FY2020CQ2 2020Jun 30, 2020$223.25M+84.4%
Q3 FY2020CQ1 2020Mar 31, 2020$217.50M+38.6%
Q2 FY2020CQ4 2019Dec 31, 2019$197.81M+25.9%
Q1 FY2020CQ3 2019Sep 30, 2019$171.10M+18.7%
Q4 FY2019CQ2 2019Jun 30, 2019$121.08M-17.6%
Q3 FY2019CQ1 2019Mar 31, 2019$156.98M+15.1%
Q2 FY2019CQ4 2018Dec 31, 2018$157.08M+7.6%
Q1 FY2019CQ3 2018Sep 30, 2018$144.13M+28.1%
Q4 FY2018CQ2 2018Jun 30, 2018$146.88M+15.3%
Q3 FY2018CQ1 2018Mar 31, 2018$136.37M+27.0%
Q2 FY2018CQ4 2017Dec 31, 2017$146.02M+50.7%
Q1 FY2018CQ3 2017Sep 30, 2017$112.56M–
Q4 FY2017CQ2 2017Jun 30, 2017$127.36M–
Q3 FY2017CQ1 2017Mar 31, 2017$107.40M–
Q2 FY2017CQ4 2016Dec 31, 2016$96.90M–

More ResMed figures

See a number that looks wrong?